Z-Medica Officially Launches QuikClot Control+

Wallingford, CT, Lake Buena Vista, FL – Z-Medica, LLC, a leading developer and marketer of hemostatic devices, announces today that QuikClot Control+ is now commercially available. The announcement is being made in advance of the 2018 EAST Annual Scientific Assembly of the Eastern Association for the Surgery of Trauma (EAST), January 9-13 at the Disney Contemporary Resort in Lake Buena Vista, Florida, where Z-Medica will be exhibiting.
Cleared by the U.S. Food and Drug Administration in June of 2017 under the de novo classification process, QuikClot Control+ is the first and only hemostatic dressing cleared for temporary control of internal organ space bleeding for patients displaying class III or class IV bleeding.
“Full commercial availability of QuikClot Control+ adds an additional life-saving tool to the arsenal of Z-Medica products that surgeons can use to help save lives and fill the unmet need of hospitals across the country,” says Z-Medica President and CEO Stephen J. Fanning. “Uncontrolled bleeding continues to be a major cause of preventable deaths. Devices like QuikClot Control+ can improve hemorrhage control, potentially savings lives and reducing healthcare costs.”
QuikClot Control+ is indicated for temporary control of internal organ space bleeding for patients displaying class III or class IV bleeding. It may also be used to control severely bleeding wounds such as surgical wounds and traumatic injuries.
What: Official launch of QuikClot Control+...

Source: JEMS Operations - January 9, 2018 Category: Emergency Medicine Authors: Z-Medica Tags: Industry News Equipment & Gear Source Type: news